tm
Seeing Is Believing
tm
Seeing Is Believing
DNLI is currently covered by 12 analysts with an average price target of $35.21. This is a potential upside of $15.83 (81.68%) from yesterday's end of day stock price of $19.38.
Denali Therapeutics's activity chart (see below) currently has 166 price targets and 155 ratings on display. The stock rating distribution of DNLI is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 31% with an average time for these price targets to be met of 98.55 days.
Highest price target for DNLI is $42, Lowest price target is $25, average price target is $33.92.
Most recent stock forecast was given by SALVEEN RICHTER from GOLDMAN SACHS on 26-Mar-2026. First documented stock forecast 02-Jan-2018.
Currently out of the existing stock ratings of DNLI, 25 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Feb-2020
$40
$19.35 (93.70%)
$40
11 days ago
(26-Mar-2026)
4/10 (40%)
$20.26 (102.63%)
127
Buy Since 07-Jan-2025
$32
$11.35 (54.96%)
$29
11 days ago
(26-Mar-2026)
0/3 (0%)
$12.26 (62.11%)
Buy Since 03-Jan-2018
$42
$21.35 (103.39%)
$30
11 days ago
(26-Mar-2026)
3/13 (23.08%)
$22.26 (112.77%)
389
Buy Since 08-Jan-2025
$41
$20.35 (98.55%)
$37
11 days ago
(26-Mar-2026)
7/14 (50%)
$21.26 (107.70%)
90
Buy Since 26-Jun-2019
$42
$21.35 (103.39%)
$32
11 days ago
(26-Mar-2026)
3/22 (13.64%)
$22.26 (112.77%)
126
What is DNLI (Denali Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on DNLI (Denali Therapeutics) with a proven track record?
Which analyst has the most public recommendations on DNLI (Denali Therapeutics)?
Which analyst is the currently most bullish on DNLI (Denali Therapeutics)?
Which analyst is the currently most reserved on DNLI (Denali Therapeutics)?
